Long noncoding RNAs (lncRNAs) are transcribed RNAs with more than 200 nucleotides in length. A growing body of evidence supports the notion that lncRNAs act as competitive endogenous RNAs for microRNAs and play roles in physiological and pathological processes. Several studies have demonstrated the roles of microRNAs in the pathogenesis of idiopathic pulmonary fibrosis (IPF). However, it is unknown whether lncRNAs are involved in IPF. To investigate the roles of lncRNAs in IPF, we determined the interaction of lncRNAs and microRNAs by motif search and manual comparison. The sequences of the dysregulated microRNAs in IPF including miR-21, miR-31, miR-101, miR-29, miR-199, and let-7d were used to search NONCODE database containing 33,829 human lncRNAs. A total of 34 lncRNAs with potential binding sites to these microRNAs were identified. We then examined the expression levels of the identified lncRNAs in the lungs of IPF patients by real-time PCR. Of 34 lncRNAs, nine lncRNAs were dysregulated in the IPF lungs. Four of them were inversely correlated to the microRNA expression in IPF. Further studies revealed that silencing the lncRNA CD99 molecule pseudogene 1 (CD99P1) inhibited proliferation and ␣-smooth muscle actin expression of lung fibroblasts, while knockdown of the lncRNA n341773 increased collagen expression in lung fibroblasts. These results suggest that CD99P1 and n341773 may be involved in the regulation of lung fibroblast proliferation and differentiation. The identification of regulatory functions of lncRNAs in lung fibroblasts may provide new research directions for the therapy of IPF.
A growing body of evidence supports the notion that lncRNAs act as competitive endogenous RNAs for microRNAs and play roles in physiological and pathological processes. Several studies have demonstrated the roles of microRNAs in the pathogenesis of idiopathic pulmonary fibrosis (IPF). However, it is unknown whether lncRNAs are involved in IPF. To investigate the roles of lncRNAs in IPF, we determined the interaction of lncRNAs and microRNAs by motif search and manual comparison. The sequences of the dysregulated microRNAs in IPF including miR-21, miR-31, miR-101, miR-29, miR-199, and let-7d were used to search NONCODE database containing 33,829 human lncRNAs. A total of 34 lncRNAs with potential binding sites to these microRNAs were identified. We then examined the expression levels of the identified lncRNAs in the lungs of IPF patients by real-time PCR. Of 34 lncRNAs, nine lncRNAs were dysregulated in the IPF lungs. Four of them were inversely correlated to the microRNA expression in IPF. Further studies revealed that silencing the lncRNA CD99 molecule pseudogene 1 (CD99P1) inhibited proliferation and ␣-smooth muscle actin expression of lung fibroblasts, while knockdown of the lncRNA n341773 increased collagen expression in lung fibroblasts. These results suggest that CD99P1 and n341773 may be involved in the regulation of lung fibroblast proliferation and differentiation. The identification of regulatory functions of lncRNAs in lung fibroblasts may provide new research directions for the therapy of IPF.
lncRNA; microRNAs; IPF RNA-SEQUENCING AND ANNOTATION reveal that the human genome produces much more noncoding RNAs than coding RNAs (4) . Long noncoding RNAs (lncRNAs) are mRNA-like transcripts (Ͼ200 nucleotides) without open reading frames. To date, only a very small number of lncRNAs have been functionally annotated, and the majority of them still need to be characterized. Recent studies have shown that lncRNAs are involved in many important biological processes such as gene imprinting, cell proliferation and differentiation, immune responses, and chromosome structure (3, 10, 23) . Furthermore, a growing number of lncRNAs have been shown to be associated with a broad range of diseases including tumors, infections, cardiovascular diseases, diabetes, and lung diseases (1, 12) . For example, lncRNA PVT1 is upregulated in nonsmall cell lung cancer, and knockdown of PVT1 inhibits the proliferation, migration, and invasion of lung cancer cells (26) . The upregulation of HOTAIR is correlated to the metastasis and poor prognosis of lung cancer (9) . LncRNAs usually perform their physiological and pathological functions by controlling gene expression at different levels such as chromatin remodeling, splicing control, mRNA degradation, and translational regulation (9 -11) . LncRNAs that have similar microRNA (miRNA) target sequences can also sequester miRNAs away from mRNAs and thus regulate the mRNA abundance (14) .
Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease with increased fibroblast proliferation and activation including collagen synthesis, and extracellular matrix deposition (5, 20) . miRNAs are a class of about 22 nucleotide noncoding small RNAs. They are important regulators in posttranscriptional gene regulation. miRNAs control gene expression by cleaving mRNA or inhibiting protein translation via the binding of miRNAs to the 3=-untranslated region (3=-UTR) of their target genes. Several studies have demonstrated the roles of miRNAs in the pathogenesis of pulmonary fibrosis. miR-21 is upregulated in the bleomycin-induced fibrotic mouse lung and also in the lungs of IPF patients. Transforming growth factor beta1 (TGF-␤1) enhances miR-21 expression in isolated primary pulmonary fibroblasts. miR-21 promotes TGF-␤1-induced fibrotic changes in pulmonary fibroblasts by targeting Smad7 (7). miR-31 regulates fibroblast activation by directly targeting integrin ␣(5) and RhoA (25) . Our unpublished results have shown that miR-101 is downregulated in the lungs of IPF and inhibits fibroblast proliferation and activation. The expression of the miR-29 family members is also significantly reduced in the bleomycin-induced fibrotic lungs. miR-29 is suppressed by TGF-␤1 treatment in human fetal lung fibroblast IMR-90 cells (2) . The expression levels of numerous profibrotic target genes are inhibited by miR-29. miR-199 is upregulated in IPF, and it controls fibroblast activation (6) . Let-7d is downregulated in the lungs of IPF patients, and TGF-␤ inhibits let-7d expression (11) . The downregulation of let-7d results in alveolar epithelial cell proliferation, epithelial-to-mesenchymal transition (EMT), and fibrotic changes in the lung.
However, whether lncRNAs interact with miRNAs to form an interacting regulatory network in IPF is still unknown. In the present study, we systematically analyzed the interaction of all registered lncRNAs in the NONCODE database and known dysregulated miRNAs in IPF. We found 34 lncRNAs to have potential binding sites to these miRNAs. Of them, nine lncRNAs were dysregulated in IPF lungs. Further studies showed that CD99P1 and n341773 are involved in the regulation of fibroblast proliferation and differentiation.
MATERIALS AND METHODS
Prediction of miRNA binding sites in lncRNAs. The sequences of 33,829 annotated human lncRNAs were downloaded from the NON-CODE database (http://www.noncode.org) and used as the prediction library. The dysregulated miRNAs in IPF, including miR-21, miR-31, miR-101, miR-29, miR-199, and let-7d, were selected to build the motifs following the previously published method with modification (21) . Motif-based sequence analysis was performed by the Web tool MEME (http://meme.nbcr.net/meme). Because one miRNA usually has hundreds of predicted targets, P value was set at 1 ϫ 10 Ϫ6 to narrow the selection. The search rules are as follows: 1) at the 5=-end of miRNA seed sequence from second to eighth positions, miRNA and lncRNA should be completely paired (one G/U pair is permitted). If the total number of mismatches within lncRNA and miRNA pairing regions is Ͻ3, the perfect seed match is not required, 2) the total of G/U pairs and mismatches within lncRNA and miRNA pairing regions should be no more than six, 3) at the 5=-end of miRNA sequence from ninth to 12th positions, bulges are permitted, and 4) the bulge size in the binding region is limited to two or three nucleotides.
IPF lung tissues and RNA isolation. Lung tissues from 28 IPF patients were obtained from the Lung Tissue Research Consortium (LTRC). These samples were submerged in RNAlater solution and stored at Ϫ80°C until use. Total RNAs were isolated using Tri 
FW, forward; RE, reverse; SMA, smooth muscle actin. Reagents (Molecular Research Center, Cincinnati, OH). RNA concentration and quality were assessed by NanoDrop ND-1000 Spectrophotometer (NanoDrop Technology, Rockland, DE). The ratios of A260/A280 and A260/A230 were Ͼ1.8 and Ͼ1.7, respectively. Human adult normal lung tissue RNAs purchased from BioChain (Newark, CA) were used as a control (n ϭ 6).
Real-time quantitative PCR. The expression levels of lncRNAs and mRNAs were determined by SYBR Green I-based real-time PCR. We reverse-transcribed 1 g of DNase-treated total RNA into cDNA using oligo dT and random primers. The real-time PCR thermal conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. Data were analyzed by the comparative delta Ct method using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an endogenous reference gene. The sequences of the primers used for real-time PCR are listed in Table 1 .
Construction of shRNA plasmids and preparation of lentiviruses. shRNAs were designed by BLOCK-iT RNAi Designer software (Invitrogen, Grand Island, NY). shRNAs were inserted into the pSIH-H1 lentiviral vector (System Biosciences, Mountain View, CA). The sequences of shRNAs are as follows: CD99P1 shRNA (siCD99P1), GCCTTTCGTGATGGAGGAAAT (GenBank accession number: NR_033381); n341773 (sin341773), GCAAAGCACAGT-TAGGATTTA (GenBank accession number: BC033399). The control vector containing scrambled shRNA was purchased from System Biosciences. Lentiviruses were produced using the Lenti-X HTX Packaging vectors (Clontech, Mountain View, CA) in human embryonic kidney 293T cells (HEK 293T). We determined the titer of virus by infecting HEK 293T cells with a series of dilutions of viral stock and counting the green fluorescent protein-positive cells.
Cell culture. LL29 cell was purchased from American Type Culture Collection (ATCC) (Manassas, VA). LL29 cells are human fibroblasts isolated from the lungs of an adult IPF patient. The cells were maintained with F12K medium supplemented with 10% fetal bovine serum.
Cell proliferation. LL29 cells were seeded in a 96-well plate and infected with a lentivirus expressing shRNA or control virus at a multiplicity of infection (MOI) of 50. After a 72 h virus infection, cell proliferation was determined using the BrdU cell proliferation kit (Millipore, Billerica, MA).
Western blotting. Protein samples were analyzed by Western blotting as previously described (19) . In brief, protein samples were separated on 12% polyacrylamide gels and electro-transferred onto nitrocellulose membranes. The membranes were blocked in TBST (50 mM Tris, pH 7.5, 150 mM NaCl, and 0.05% Tween 20) containing 5% dried milk. After being blocked, the membranes were incubated with mouse anti-alpha smooth muscle actin (anti-␣-SMA, 1:1,000) (Sigma, St. Louis, MO) or mouse anti-GAPDH (1:4,000) antibodies in TBST containing 5% dried milk overnight on a shaker at 4°C. After incubation, membranes were washed with TBST three times for 5 min each and incubated with horseradish peroxidase-conjugated antimouse IgG at a dilution of 1:5,000 in TBST containing 5% dried milk for 1 h. The membranes were washed with TBST three times for 5 min each. Bands were developed with Super Signal West Pico Luminol Enhancer solution and Super Signal West Pico Stable Peroxidase solution.
Statistical analysis. Data presented in the figures are means Ϯ SE. Statistical analyses were performed by Student's t-test, and a P value of Ͻ0.05 was considered to be significant.
RESULTS

Identification of lncRNAs that have miRNA binding sites in IPF.
It is well known that miRNAs regulate gene expression by binding the 3=-UTRs of their target mRNAs. Recent studies show that lncRNAs can compete with miRNAs for binding sites on target mRNAs. miR-21, miR-31, miR-101, miR-29, miR-199, and let-7d are involved in the pathogenesis of pulmonary fibrosis. To investigate the interaction of lncRNAs and these miRNAs, we used the previously published method to predict binding sites of these six miRNAs in the NONCODE database (21) . We constructed miRNA motifs based on the miRNA mature sequences. We then searched the NONCODE database including 33,829 human lncRNAs using the miRNA motifs. We found that a total of 34 lncRNAs had the potential binding sites of these miRNAs. Among these lncRNAs, n341975 had binding sites for miR-101 and miR-29a. Thus, a total of 35 lncRNA-miRNA interactions were identified (Table 2 and Fig. 1) .
Expression of lncRNAs in IPF patient lungs. To determine whether these predicted lncRNAs were indeed transcribed in the human lungs, we examined the expression of the identified lncRNAs above in human adult normal lung tissue with realtime PCR. Among 34 lncRNAs, 23 lncRNAs were found to be expressed in human lung tissues (Fig. 2) . Of them, the expression level of n381899 was the highest and that of n382409 was the lowest in the lungs.
We then examined the expression levels of these 23 lncRNAs in the lungs of IPF patients. These patients were divided into three groups based on the values of prebronchodilator forced vital capacity (FVC): Ͻ50% predicted FVC group (n ϭ 10), 50 -80% predicted FVC group (n ϭ 10), and Ͼ80% predicted FVC group (n ϭ 8). Human adult normal lung tissue RNAs were used as a control. Among 23 lncRNAs, nine lncRNAs were found to be dysregulated in IPF (Fig. 3) . Six lncRNAs, n370929, CD99P1, NR_003085, n338680, n341773, and n364035, were downregulated in IPF; three lncRNAs, n342143, n373263, and NR_045756, were upregulated in IPF. Four lncRNAs were inversely related to miRNA expression in IPF. n341773 and n364035 were inversely correlated to miR-199. NR_045756 and n373263 were inversely correlated to miR-31 and let-7d, respectively ( Table 2) .
Effects of n341773 and CD99P1 on ␣-SMA and collagen expression in lung fibroblasts. We attempted to knock down the nine dysregulated lncRNAs identified above using lentiviral shRNAs in lung fibroblasts, LL29. We were successful in knocking down the expression of n341773 and CD99P1 (Fig.  4) . We found that the mRNA expression of ␣-SMA and collagen genes (COL1A1, COL3A1, and COL4A1) was increased by n341773 knockdown in LL29 fibroblasts (Fig. 5) . However, ␣-SMA mRNA and protein levels were suppressed by CD99P1 knockdown (Fig. 6, A and B) .
Effects of n341773 and CD99P1 on fibroblast proliferation. Recent studies have shown that lncRNAs are involved in cell proliferation. For example, lncRNA HOTAIR increases the Fig. 1 . Binding alignments of 34 long noncoding RNAs (lncRNAs) with microRNA (miR)-21, miR-31, miR-101, miR-29, miR-199, and let-7d. These dysregulated miRNAs in the lungs of idiopathic pulmonary fibrosis (IPF) patients were selected from previously reports, and lncRNAs were predicted by motif-based sequence analysis using the web tool MEME.
cell proliferation and invasion of renal carcinoma cells in vitro (22) ; lncRNA MALAT1 regulates retinal endothelial cell proliferation (8) . The proliferation of residential lung fibroblasts is one of the major contributors to the increase in the number of fibroblasts in fibroblastic foci of IPF. We thus determined the effects of lncRNA n341773 and CD99P1 knockdown on lung fibroblast proliferation using LL29 cells. We found that CD99P1 knockdown significantly reduced fibroblast proliferation, while n341773 knockdown increased fibroblast proliferation although it did reach a significant level (P ϭ 0.053) (Fig. 7) .
DISCUSSION
The majority of the genome is transcribed. However, only about 2% of the mammalian genome has protein-coding ability. In mammalian cells, the major transcription products are noncoding RNA, including lncRNAs with Ͼ200 nucleotides in length. Recent studies have begun to clarify the role of lncRNAs in human diseases. However, the expression profiles and functions of lncRNAs in IPF are still unknown. A growing body of evidence supports the notion that lncRNAs act as miRNA sponges/decoys and play roles in physiological and pathological conditions (16, 24) . Previously, studies have demonstrated the roles of miRNA in the pathogenesis of IPF. In the present study, we systematically screened human lncRNA database and identified 34 lncRNAs that have potential binding sites of the dysregulated miRNAs in IPF, including miR-21, miR-31, miR-101, miR-29, miR-199, and let-7d.
A recent study investigated the role of lncRNA MRAK088388 and MRAK081523 as competitive endogenous RNAs (ceRNAs) in pulmonary fibrosis (18) . In that published study, lncRNAs were selected as baits to identify miRNAs that have binding sites on them. miR-29 and let-7, dysregulated miRNAs in IPF, were found to interact with these two lncRNAs. In our study, dysregulated miRNAs in IPF were used as bait to systematically screen all registered lncRNAs in the NONCODE database. In addition, we examined the expression patterns of the identified lncRNAs in the lungs of IPF patients. Furthermore, we correlated the dysregulated lncRNAs to the dysregulated miRNAs and explored the function of lncRNAs n341773 and CD99P1 in lung fibroblasts. A growing number of miRNAs have been found to play roles in IPF. The limitation of the present study is that we only analyzed dysregulated functional miRNAs in IPF but not all the registered miRNAs in the miRbase database. The expression levels were relative to GAPDH. Fold change was calculated based on the normal human lung tissue (CON). Results are presented as means Ϯ SE. *P Ͻ 0.05 vs CON. n ϭ 6 for normal human lung tissue control group; n ϭ 8 for Ͼ80% predicted forced vital capacity (FVC) group; n ϭ 10 for 50 -80% predicted FVC group; and n ϭ 10 for Ͻ50% predicted FVC group.
The proliferation of resident fibroblasts leads to an increase in the number of fibroblasts in the fibroblastic foci (15) . These foci contain activated myofibroblasts, which are differentiated from fibroblasts and characterized by induced ␣-SMA expression and an increase in collagen synthesis. In this study, we found that lncRNA n341773 had the binding sites for miR-199 and reduction of the lncRNA n341773 level in LL29 fibroblasts increased the expression of ␣-SMA and collagen genes. On the other hand, miR-199 has been reported to be a profibrotic miRNA and is involved in the pathogenic activation of pulmonary fibroblasts including cell proliferation and differentiation into myofibroblasts (6, 17) . Furthermore, lncRNA n341773 is downregulated (Fig. 3) and miR-199 is upregulated in IPF lungs (6, 17) . Thus, the expression and function of lncRNA n341773 in IPF are inversely correlated to those of miR-199. These results suggest that lncRNA n341773 may function as a ceRNA for miR-199 in lung fibroblasts.
LncRNA CD99P1 knockdown reduced ␣-SMA mRNA and protein expression and fibroblast proliferation. Since ␣-SMA is the hallmark of fibroblast differentiation into myofibroblast, CD99P1 may be involved in both fibroblast proliferation and differentiation. To our knowledge, this is the first report to show that lncRNA CD99P1 regulates fibroblasts' function.
Although CD99P1 has the binding site for miR-101, CD99P1 expression and function are not inversely correlated to those of miR-101, because miR-101 is downregulated in the lungs and miR-101 inhibits lung fibroblast proliferation and differentiation (our unpublished data). Thus CD99P1 is unlikely to function as a ceRNA. CD99P1 is a CD99 molecule-like 1 pseudogene. The CD99 molecule is a cell surface glycoprotein that regulates cell proliferation, migration, and metastasis of Ewing sarcoma cells (13) . Whether CD99P1 controls fibroblast proliferation and differentiation via the CD99 molecule remains to be determined. In summary, we identified 34 lncRNAs that have potential binding sites for dysregulated miRNAs in IPF. Nine of these were also dysregulated in IPF. Furthermore, lncRNA n341773 increased collagen expression of lung fibroblasts and CD99P1 inhibited lung fibroblast proliferation and myofibroblast differentiation.
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